Andrew Wang
Impact in
-
- Cardiomyopathy and Myosin Studies
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Epidemiology top 0.5%
- Infective Endocarditis Diagnosis and Management
Papers in
-
- Cardiomyopathy and Myosin Studies 72
- Cardiac Valve Diseases and Treatments 53
- Epidemiology 48
- Infective Endocarditis Diagnosis and Management 47
- Co-authors
- Vivian H. Chu (12 shared papers)Thomas M. Bashore (27 shared papers)Jeffrey G. Gaca (16 shared papers)Christopher H. Cabell (10 shared papers)Vance G. Fowler (8 shared papers)Donald Duane Glower (23 shared papers)G. Ralph Corey (6 shared papers)John Kevin Harrison (31 shared papers)
- Journals
- Journal of the American College of Cardiology (40 papers)European Heart Journal (14 papers)American Heart Journal (14 papers)Circulation (11 papers)The American Journal of Cardiology (10 papers)
- Partner nations
- United StatesSpainDenmark
In The Last Decade
Andrew Wang
206 papers receiving 10.1k citations
Andrew Wang's Hit Papers
Peers
Comparison fields: 5 of 125
- Cardiology and Cardiovascular Medicine 5.6k
- Epidemiology 3.1k
- Nephrology 619
- Critical Care and Intensive Care Medicine 75
- Pulmonary and Respiratory Medicine 483
Countries citing papers authored by Andrew Wang
This map shows the geographic impact of Andrew Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Wang more than expected).
Fields of papers citing papers by Andrew Wang
This network shows the impact of papers produced by Andrew Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Wang. The network helps show where Andrew Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 868 |
| 2 | Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation Hit paper breakdown → | 2015 | 640 |
| 3 | Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis Hit paper breakdown → | 2007 | 534 |
| 4 | 2004 | 350 | |
| 5 | 2013 | 334 | |
| 6 | 2003 | 315 | |
| 7 | Management Considerations in Infective Endocarditis Hit paper breakdown → | 2018 | 267 |
| 8 | Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy Hit paper breakdown → | 2020 | 256 |
| 9 | 2019 | 244 | |
| 10 | 2013 | 243 | |
| 11 | 2010 | 237 | |
| 12 | 2014 | 228 | |
| 13 | 2013 | 193 | |
| 14 | 2011 | 186 | |
| 15 | 2000 | 180 | |
| 16 | 2020 | 177 | |
| 17 | 1998 | 175 | |
| 18 | 2007 | 172 | |
| 19 | 2016 | 164 | |
| 20 | Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy Hit paper breakdown → | 2023 | 159 |
About Andrew Wang
Andrew Wang is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Pulmonary and Respiratory Medicine, Nephrology and Public Health, Environmental and Occupational Health, having authored 218 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (72 papers), Cardiac Valve Diseases and Treatments (53 papers), Infective Endocarditis Diagnosis and Management (47 papers), Innovations in Medical Education (7 papers), Pulmonary Hypertension Research and Treatments (6 papers), Acute Kidney Injury Research (5 papers), Aortic Disease and Treatment Approaches (5 papers) and Coronary Interventions and Diagnostics (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.6k citations), Epidemiology (3.1k citations), Nephrology (619 citations), Critical Care and Intensive Care Medicine (75 citations) and Pulmonary and Respiratory Medicine (483 citations). Andrew Wang has collaborated with scholars based in United States, Spain and Denmark. Frequent co-authors include Vivian H. Chu, Thomas M. Bashore, Jeffrey G. Gaca, Christopher H. Cabell, Vance G. Fowler, Donald Duane Glower, G. Ralph Corey, John Kevin Harrison, Amy J. Sehnert and Daniel J Sexton. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal, American Heart Journal, Circulation and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.